|
|
|
Volumn , Issue JANUARY-FEBRUARY, 2010, Pages 13-
|
|
Oncotype DX can predict risk in node-positive patients
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ESTROGEN RECEPTOR;
FLUOROURACIL;
TAMOXIFEN;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER RISK;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DISEASE FREE SURVIVAL;
HUMAN;
LYMPH NODE;
SHORT SURVEY;
|
|
EID: 77749283042
PISSN: 15485323
EISSN: 15485323
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
